Core Viewpoint - Green Thumb Industries Inc. has increased its syndicated credit facility by $50 million, totaling $189 million, to support general corporate purposes and potential strategic investments [1][2]. Group 1: Financial Details - The credit facility is led by Valley National Bank and has a maturity date of September 11, 2029, with an interest rate of Secured Overnight Financing Rate (SOFR) + 500 basis points [2]. - The additional funds will be utilized for general corporate purposes, potential strategic investments, and other working capital requirements [1]. Group 2: Company Overview - Green Thumb Industries is a leading national cannabis consumer packaged goods company headquartered in Chicago, Illinois, operating RISE Dispensaries [3]. - The company manufactures and distributes a portfolio of licensed, branded cannabis products and serves millions of patients and customers annually [3]. - Established in 2014, Green Thumb operates 20 manufacturing facilities and over 100 retail stores across 14 U.S. markets, employing approximately 5,000 people [3].

Core Viewpoint - Collegium Pharmaceutical, Inc. has successfully closed its inaugural syndicated credit facility of $980 million, which will enhance its financial flexibility and support future business development opportunities [1][2]. Group 1: Credit Facility Details - The credit facility consists of a $580 million initial Term Loan, a $300 million Delayed Draw Term Loan, and a $100 million revolving credit facility, maturing in 2030 [1]. - The initial Term Loan was utilized to repay approximately $581 million of the previous $646 million term loan [1]. - The interest rate for the loans under the Credit Facility is based on the Secured Overnight Financing Rate (SOFR) plus a spread of 2.75% to 3.75%, with the closing rate set at SOFR plus 2.75% [2]. Group 2: Financial Outlook and Strategy - The new credit facility is expected to result in significant annualized interest savings, improving the company's debt terms [2]. - The additional capital will provide the company with the flexibility to pursue long-term value through the expansion and diversification of its product portfolio [2]. - Collegium is focused on growing its commercial portfolio, particularly through its leading product Jornay PM, which is aimed at ADHD treatment [3].